peroxynitrous acid has been researched along with butaprost in 1 studies
| Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (butaprost) | Trials (butaprost) | Recent Studies (post-2010) (butaprost) |
|---|---|---|---|---|---|
| 3,303 | 21 | 1,230 | 161 | 0 | 46 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachschmid, MM; Clavreul, N; Cohen, RA; Hou, X; Ido, Y; Idrizovic, A; Pimentel, D; Shi, C | 1 |
1 other study(ies) available for peroxynitrous acid and butaprost
| Article | Year |
|---|---|
S-glutathiolation of p21ras by peroxynitrite mediates endothelial insulin resistance caused by oxidized low-density lipoprotein.
Topics: Alprostadil; Animals; Aorta; Cattle; Dinoprostone; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Glutathione; Glutathione Disulfide; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipoproteins, LDL; Lysophosphatidylcholines; Oncogene Protein p21(ras); Oxidants; Peroxynitrous Acid; Phosphoproteins; Phosphorylation; Prostaglandins E, Synthetic; Signal Transduction | 2006 |